Strategic Opportunity Assessment
SITUATION
A small cap clinical stage company wished to understand the impact their novel mode of administration (MOA) would have on switching patients from the currently available product​. The goal was to assess future uptake and demand by segment as well as the most important product attributes by stakeholder to support future demand estimates​.
OUR ROLE
Spinnaker conducted web-based quantitative surveys, incorporating Adaptive Choice-Based Conjoint (ACBC) modeling, with multiple stakeholders including physicians, patients, and caregivers​. Spinnaker also conducted quantitative surveys with patients who had the condition but were currently not on therapy​.
IMPACT
Spinnaker created an in-depth analysis as well as a “what-if” simulator the company could use to model different scenarios, interlocking all stakeholders​. Data was used to inform and update the company’s forecast and investor deck, and the company presented findings at multiple large national medical conferences​.
